Hypolipidemic and antiatherogenic effects of Cynara scolymus in cholesterol-fed rats
Autor(a) principal: | |
---|---|
Data de Publicação: | 2016 |
Outros Autores: | , , , , , , , , , , , , , |
Tipo de documento: | Artigo |
Idioma: | eng |
Título da fonte: | Revista Brasileira de Farmacognosia (Online) |
Texto Completo: | http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0102-695X2016000200233 |
Resumo: | ABSTRACT Cynara scolymus L., Asteraceae, are traditionally used to treat dyspepsia. This study evaluated the hypolipidemic and antiatherogenic effects of an aqueous extract prepared from the leaves of C. scolymus in rat's model. Hypercholesterolemic rats (1% cholesterol and 0.5% cholic acid for 15 days) were treated (0.5 ml/200 g) with extract of C. scolymus (150, 300, or 600 mg/kg p.o.; n = 6) or simvastatin (4 mg/kg p.o.; n = 6) once per day for 30 days along with hypercaloric diet. A control group (C) was given water (0.5 ml/200 g; n = 6). A high-cholesterol diet was maintained throughout the treatment period. Rats treated with extract of C. scolymus (150, 300, or 600 mg/kg) and simvastatin showed significant decreases in serum levels of total cholesterol (−46.9%, −51.9%, −44%, and −41.9%, respectively) and low-density lipoprotein-cholesterol (LDL-C; −52.1%, −54.8%, −51.9%, and −46.7%, respectively), compared with group C (p < 0.005). Biochemical analyses revealed significant decrease in the concentration of IL-1, IL-6, TNF-α, IFN-γ, C-reactive protein, oxidized-LDL, and antioxidized-LDL in rats treated with extract of C. scolymus (150, 300, or 600 mg/kg). There were no differences in serum ALT enzyme activity between the groups. Our results suggest that hypolipidemic and antiatherogenic effects could be related with the presence of polar substances present in aqueous extract of C. scolymus. |
id |
SBFGNOSIA-1_36a9d1ee12781c22b4ddb2e9d4ccceca |
---|---|
oai_identifier_str |
oai:scielo:S0102-695X2016000200233 |
network_acronym_str |
SBFGNOSIA-1 |
network_name_str |
Revista Brasileira de Farmacognosia (Online) |
repository_id_str |
|
spelling |
Hypolipidemic and antiatherogenic effects of Cynara scolymus in cholesterol-fed ratsAntihyperlipidemicAntiatherogenicArtichokeAsteraceaeCholesterolABSTRACT Cynara scolymus L., Asteraceae, are traditionally used to treat dyspepsia. This study evaluated the hypolipidemic and antiatherogenic effects of an aqueous extract prepared from the leaves of C. scolymus in rat's model. Hypercholesterolemic rats (1% cholesterol and 0.5% cholic acid for 15 days) were treated (0.5 ml/200 g) with extract of C. scolymus (150, 300, or 600 mg/kg p.o.; n = 6) or simvastatin (4 mg/kg p.o.; n = 6) once per day for 30 days along with hypercaloric diet. A control group (C) was given water (0.5 ml/200 g; n = 6). A high-cholesterol diet was maintained throughout the treatment period. Rats treated with extract of C. scolymus (150, 300, or 600 mg/kg) and simvastatin showed significant decreases in serum levels of total cholesterol (−46.9%, −51.9%, −44%, and −41.9%, respectively) and low-density lipoprotein-cholesterol (LDL-C; −52.1%, −54.8%, −51.9%, and −46.7%, respectively), compared with group C (p < 0.005). Biochemical analyses revealed significant decrease in the concentration of IL-1, IL-6, TNF-α, IFN-γ, C-reactive protein, oxidized-LDL, and antioxidized-LDL in rats treated with extract of C. scolymus (150, 300, or 600 mg/kg). There were no differences in serum ALT enzyme activity between the groups. Our results suggest that hypolipidemic and antiatherogenic effects could be related with the presence of polar substances present in aqueous extract of C. scolymus.Sociedade Brasileira de Farmacognosia2016-04-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersiontext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S0102-695X2016000200233Revista Brasileira de Farmacognosia v.26 n.2 2016reponame:Revista Brasileira de Farmacognosia (Online)instname:Sociedade Brasileira de Farmacognosia (SBFgnosia)instacron:SBFGNOSIA10.1016/j.bjp.2015.11.004info:eu-repo/semantics/openAccessMocelin,RicieriMarcon,MatheusSanto,Glaucia D.Zanatta,LeilaSachett,AdrieliSchönell,Amanda P.Bevilaqua,FernandaGiachini,MartaChitolina,RafaelWildner,Silvana M.Duarte,Marta M.M.F.Conterato,Greicy M.M.Piato,Angelo L.Gomes,Denise B.Roman Junior,Walter A.eng2016-11-30T00:00:00Zoai:scielo:S0102-695X2016000200233Revistahttp://www.sbfgnosia.org.br/revista/https://old.scielo.br/oai/scielo-oai.phprbgnosia@ltf.ufpb.br1981-528X0102-695Xopendoar:2016-11-30T00:00Revista Brasileira de Farmacognosia (Online) - Sociedade Brasileira de Farmacognosia (SBFgnosia)false |
dc.title.none.fl_str_mv |
Hypolipidemic and antiatherogenic effects of Cynara scolymus in cholesterol-fed rats |
title |
Hypolipidemic and antiatherogenic effects of Cynara scolymus in cholesterol-fed rats |
spellingShingle |
Hypolipidemic and antiatherogenic effects of Cynara scolymus in cholesterol-fed rats Mocelin,Ricieri Antihyperlipidemic Antiatherogenic Artichoke Asteraceae Cholesterol |
title_short |
Hypolipidemic and antiatherogenic effects of Cynara scolymus in cholesterol-fed rats |
title_full |
Hypolipidemic and antiatherogenic effects of Cynara scolymus in cholesterol-fed rats |
title_fullStr |
Hypolipidemic and antiatherogenic effects of Cynara scolymus in cholesterol-fed rats |
title_full_unstemmed |
Hypolipidemic and antiatherogenic effects of Cynara scolymus in cholesterol-fed rats |
title_sort |
Hypolipidemic and antiatherogenic effects of Cynara scolymus in cholesterol-fed rats |
author |
Mocelin,Ricieri |
author_facet |
Mocelin,Ricieri Marcon,Matheus Santo,Glaucia D. Zanatta,Leila Sachett,Adrieli Schönell,Amanda P. Bevilaqua,Fernanda Giachini,Marta Chitolina,Rafael Wildner,Silvana M. Duarte,Marta M.M.F. Conterato,Greicy M.M. Piato,Angelo L. Gomes,Denise B. Roman Junior,Walter A. |
author_role |
author |
author2 |
Marcon,Matheus Santo,Glaucia D. Zanatta,Leila Sachett,Adrieli Schönell,Amanda P. Bevilaqua,Fernanda Giachini,Marta Chitolina,Rafael Wildner,Silvana M. Duarte,Marta M.M.F. Conterato,Greicy M.M. Piato,Angelo L. Gomes,Denise B. Roman Junior,Walter A. |
author2_role |
author author author author author author author author author author author author author author |
dc.contributor.author.fl_str_mv |
Mocelin,Ricieri Marcon,Matheus Santo,Glaucia D. Zanatta,Leila Sachett,Adrieli Schönell,Amanda P. Bevilaqua,Fernanda Giachini,Marta Chitolina,Rafael Wildner,Silvana M. Duarte,Marta M.M.F. Conterato,Greicy M.M. Piato,Angelo L. Gomes,Denise B. Roman Junior,Walter A. |
dc.subject.por.fl_str_mv |
Antihyperlipidemic Antiatherogenic Artichoke Asteraceae Cholesterol |
topic |
Antihyperlipidemic Antiatherogenic Artichoke Asteraceae Cholesterol |
description |
ABSTRACT Cynara scolymus L., Asteraceae, are traditionally used to treat dyspepsia. This study evaluated the hypolipidemic and antiatherogenic effects of an aqueous extract prepared from the leaves of C. scolymus in rat's model. Hypercholesterolemic rats (1% cholesterol and 0.5% cholic acid for 15 days) were treated (0.5 ml/200 g) with extract of C. scolymus (150, 300, or 600 mg/kg p.o.; n = 6) or simvastatin (4 mg/kg p.o.; n = 6) once per day for 30 days along with hypercaloric diet. A control group (C) was given water (0.5 ml/200 g; n = 6). A high-cholesterol diet was maintained throughout the treatment period. Rats treated with extract of C. scolymus (150, 300, or 600 mg/kg) and simvastatin showed significant decreases in serum levels of total cholesterol (−46.9%, −51.9%, −44%, and −41.9%, respectively) and low-density lipoprotein-cholesterol (LDL-C; −52.1%, −54.8%, −51.9%, and −46.7%, respectively), compared with group C (p < 0.005). Biochemical analyses revealed significant decrease in the concentration of IL-1, IL-6, TNF-α, IFN-γ, C-reactive protein, oxidized-LDL, and antioxidized-LDL in rats treated with extract of C. scolymus (150, 300, or 600 mg/kg). There were no differences in serum ALT enzyme activity between the groups. Our results suggest that hypolipidemic and antiatherogenic effects could be related with the presence of polar substances present in aqueous extract of C. scolymus. |
publishDate |
2016 |
dc.date.none.fl_str_mv |
2016-04-01 |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article |
dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0102-695X2016000200233 |
url |
http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0102-695X2016000200233 |
dc.language.iso.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
10.1016/j.bjp.2015.11.004 |
dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
text/html |
dc.publisher.none.fl_str_mv |
Sociedade Brasileira de Farmacognosia |
publisher.none.fl_str_mv |
Sociedade Brasileira de Farmacognosia |
dc.source.none.fl_str_mv |
Revista Brasileira de Farmacognosia v.26 n.2 2016 reponame:Revista Brasileira de Farmacognosia (Online) instname:Sociedade Brasileira de Farmacognosia (SBFgnosia) instacron:SBFGNOSIA |
instname_str |
Sociedade Brasileira de Farmacognosia (SBFgnosia) |
instacron_str |
SBFGNOSIA |
institution |
SBFGNOSIA |
reponame_str |
Revista Brasileira de Farmacognosia (Online) |
collection |
Revista Brasileira de Farmacognosia (Online) |
repository.name.fl_str_mv |
Revista Brasileira de Farmacognosia (Online) - Sociedade Brasileira de Farmacognosia (SBFgnosia) |
repository.mail.fl_str_mv |
rbgnosia@ltf.ufpb.br |
_version_ |
1752122469727076352 |